ARAKEL DAVTIAN: Open Payments
NPI 1275584260 · GLENDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$272 in 7 payments from 2 companies in 2025. Trend: 2023 $627 · 2024 $243 · 2025 $272
Food & beverage: $272
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 4 | $192 |
| Otsuka America Pharmaceutical, Inc. | 3 | $80 |
Products named: LYBALVI, ARISTADA, REXULTI, ABILIFY ASIMTUFII, ABILIFY MAINTENA.
Industry payments across CA — which companies pay providers there.
